Loading...
Pear Therapeutics, Inc.
PEARW•NASDAQ
Healthcare
Medical - Healthcare Information Services
$0.006
$0.00(0.00%)
Pear Therapeutics, Inc. (PEARW) Company Profile & Overview
Explore Pear Therapeutics, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Pear Therapeutics, Inc. (PEARW) Company Profile & Overview
Pear Therapeutics, Inc. engages in developing and commercializing software-based medicines. The company has a pipeline of products and product candidates across therapeutic areas, including severe psychiatric and neurologic conditions. Its products include PearConnect, a patient service center for prescription digital therapeutics; reSET for the treatment of substance use disorder; reSET-O for the treatment of opioid use disorder; and Somryst for the treatment of chronic insomnia. The company was founded in 2013 and is based in Boston, Massachusetts.
SectorHealthcare
IndustryMedical - Healthcare Information Services
CEOCorey M. McCann
Contact Information
Company Facts
200 Employees
CountryUS